Answer
It can inhibit CYP3A4, increase encorafenib exposure and make adverse effects more likely.
Sources for this answer
- Braftovi 75 mg hard capsule — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.